NGL Fine Chem - NGL Fine - Chem Share Price

1,313.6062.50 (5.00%)
Volume: 4,564

Closed
Last Updated On: 19 May, 2025, 03:05 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

NGL Fine Chem - NGL Fine - Chem Share Price

1,313.6062.50 (5.00%)
Volume: 4,564

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

NGL Fine Chem share price insights

View All

Board Meeting on May 22, 2025
Meeting Agenda: Audited Results & Final Dividend. Please add to watchlist to track closely.
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 13.32% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Decrease in Cash from Investing
Company has used Rs 26.82 cr for investing activities which is an YoY decrease of 0.75%. (Source: Consolidated Financials)
NGL Fine Chem Share Price Update
NGL Fine - Chem Ltd. share price moved up by 5.00% from its previous close of Rs 1,251.10. NGL Fine - Chem Ltd. stock last traded price is 1,313.60
Share Price Value
Today/Current/Last 1,313.601,307.10
Previous Day 1,251.101,244.90

Share Price	Value
Today/Current/Last	1,313.601,307.10
Previous Day	1,251.101,244.90

InsightsNGL Fine Chem

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

24.87

EPS - TTM

(₹)

52.82

MCap

(₹ Cr.)

680.94

Sectoral MCap Rank

PB Ratio

(x)

2.59

Div Yield

(%)

0.13

Face Value

(₹)

5.00

Beta

VWAP

(₹)

1,307.26

52W H/L

(₹)

2,777.95 / 957.00

NGL Fine Chem Share Price Returns

1 Day	5.0%
1 Week	18.45%
1 Month	26.3%
3 Months	30.38%
1 Year	-43.85%
3 Years	N.A.
5 Years	N.A.

ET Stock ScreenersTop Score Companies

Check whether NGL Fine Chem belongs to analysts' top-rated companies list?

View Stock Screeners

NGL Fine Chem News & Analysis

View all NGL Fine Chem Share News & Announcements

NGL Fine Chem Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

NGL Fine Chem Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 13.32% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	88.97	98.60	96.64	103.44	91.63
Total Income Growth (%)	-9.77	2.03	-6.58	12.89	9.87
Total Expenses	87.10	84.95	84.41	86.86	77.03
Total Expenses Growth (%)	2.53	0.65	-2.82	12.76	11.47
EBIT	1.87	13.65	12.23	16.58	14.60
EBIT Growth (%)	-86.33	11.58	-26.24	13.54	2.14
Profit after Tax (PAT)	1.28	9.81	9.22	12.32	10.03
PAT Growth (%)	-86.99	6.44	-25.20	22.83	-4.24
EBIT Margin (%)	2.10	13.84	12.66	16.03	15.94
Net Profit Margin (%)	1.43	9.95	9.54	11.91	10.95
Basic EPS (₹)	2.07	15.88	14.92	19.95	16.24

Quarterly \| Annual	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	86.98	96.84	94.30	99.77	89.00
Total Income Growth (%)	-10.18	2.69	-5.48	12.10	6.97
Total Expenses	85.57	83.09	83.86	85.08	75.93
Total Expenses Growth (%)	2.98	-0.91	-1.44	12.05	11.13
EBIT	1.41	13.75	10.45	14.70	13.07
EBIT Growth (%)	-89.73	31.61	-28.92	12.43	-12.14
Profit after Tax (PAT)	0.78	10.04	7.83	10.85	8.90
PAT Growth (%)	-92.21	28.35	-27.87	21.95	-18.90
EBIT Margin (%)	1.62	14.20	11.08	14.73	14.69
Net Profit Margin (%)	0.90	10.37	8.30	10.87	10.00
Basic EPS (₹)	1.27	16.26	12.67	17.56	14.40

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	352.82	283.61	328.19	265.99	154.74
Total Revenue Growth (%)	24.40	-13.58	23.38	71.90	-1.63
Total Expenses	298.40	256.25	261.59	188.40	142.66
Total Expenses Growth (%)	16.45	-2.04	38.85	32.06	9.97
Profit after Tax (PAT)	41.32	20.50	49.90	56.72	8.34
PAT Growth (%)	101.58	-58.92	-12.03	580.47	-58.59
Operating Profit Margin (%)	16.46	10.27	21.46	30.78	9.44
Net Profit Margin (%)	12.19	7.37	15.71	21.98	5.49
Basic EPS (₹)	66.88	33.18	80.77	91.81	13.49

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	344.87	282.66	331.31	266.73	155.52
Total Revenue Growth (%)	22.01	-14.68	24.21	71.51	-1.13
Total Expenses	294.17	256.07	262.33	190.73	141.16
Total Expenses Growth (%)	14.88	-2.39	37.54	35.11	8.82
Profit after Tax (PAT)	38.52	20.12	52.25	55.47	10.60
PAT Growth (%)	91.46	-61.49	-5.81	423.12	-47.32
Operating Profit Margin (%)	15.82	10.10	22.13	30.14	10.91
Net Profit Margin (%)	11.70	7.31	16.39	21.48	6.96
Basic EPS (₹)	62.35	32.56	84.57	89.79	17.16

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	355.54	287.08	276.93	207.77	153.62
Total Assets Growth (%)	23.85	3.67	33.29	35.25	8.04
Total Liabilities	92.90	64.53	73.71	53.31	54.66
Total Liabilities Growth (%)	43.97	-12.45	38.27	-2.47	9.17
Total Equity	262.63	222.55	203.22	154.46	98.96
Total Equity Growth (%)	18.01	9.51	31.57	56.08	7.42
Current Ratio (x)	2.46	2.79	2.64	2.95	1.88
Total Debt to Equity (x)	0.12	0.14	0.13	0.07	0.23
Contingent Liabilities	19.86	14.11	14.83	7.86	2.49

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	353.05	288.11	277.72	206.18	155.58
Total Assets Growth (%)	22.54	3.74	34.70	32.52	9.42
Total Liabilities	90.24	62.59	71.16	50.72	54.38
Total Liabilities Growth (%)	44.18	-12.04	40.30	-6.73	8.61
Total Equity	262.81	225.52	206.56	155.45	101.20
Total Equity Growth (%)	16.54	9.18	32.88	53.61	9.86
Current Ratio (x)	2.41	2.81	2.69	3.12	1.93
Total Debt to Equity (x)	0.12	0.14	0.13	0.07	0.23
Contingent Liabilities	19.40	13.90	14.42	7.75	1.70

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 20.47 cr is 0.5 times compared to the reported net profit of Rs 41.32 cr. (Source: Consolidated Financials)
Decrease in Cash from Investing
Company has used Rs 26.82 cr for investing activities which is an YoY decrease of 0.75%. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	20.47	35.29	13.82	27.35	20.46
Net Cash used in Investing Activities	-26.82	-27.02	-14.20	-24.57	-20.85
Net Cash flow from Financing Activities	-1.08	-1.08	-1.08	-1.08	-
Net Cash Flow	-7.43	7.18	-1.46	1.70	-0.39
Closing Cash & Cash Equivalent	0.40	7.83	0.64	2.10	0.40
Closing Cash & Cash Equivalent Growth (%)	-94.95	1,115.97	-69.39	427.33	-49.44
Total Debt/ CFO (x)	1.59	0.86	1.94	0.40	1.12

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	11.14	31.89	12.69	26.57	19.62
Net Cash used in Investing Activities	-17.49	-23.62	-13.00	-23.79	-20.09
Net Cash flow from Financing Activities	-1.08	-1.08	-1.08	-1.08	-
Net Cash Flow	-7.44	7.19	-1.40	1.71	-0.46
Closing Cash & Cash Equivalent	0.39	7.82	0.64	2.03	0.33
Closing Cash & Cash Equivalent Growth (%)	-95.06	1,128.25	-68.66	522.54	-58.63
Total Debt/ CFO (x)	2.91	0.96	2.12	0.41	1.17

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	15.73	9.20	24.55	36.72	8.42
Return on Capital Employed (%)	20.73	12.48	32.26	47.95	12.95
Return on Assets (%)	11.62	7.13	18.01	27.29	5.42
Interest Coverage Ratio (x)	50.37	33.29	50.29	47.69	9.95
Asset Turnover Ratio (x)	1.05	0.97	1.31	1.44	1.02
Price to Earnings (x)	31.35	36.10	24.27	16.72	18.80
Price to Book (x)	4.92	3.32	5.95	6.13	1.58
EV/EBITDA (x)	19.61	18.99	15.73	10.86	7.86
EBITDA Margin (%)	19.89	14.33	24.73	34.02	14.79

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	14.65	8.92	25.29	35.68	10.47
Return on Capital Employed (%)	19.37	12.00	32.86	46.72	14.72
Return on Assets (%)	10.91	6.98	18.81	26.90	6.81
Interest Coverage Ratio (x)	44.98	29.82	50.08	42.30	7.37
Asset Turnover Ratio (x)	1.03	0.97	1.32	125.22	97.81
Price to Earnings (x)	33.56	36.76	23.20	17.09	14.77
Price to Book (x)	4.91	3.28	5.86	6.09	1.55
EV/EBITDA (x)	21.96	21.21	15.80	11.19	7.39
EBITDA Margin (%)	18.29	12.97	24.54	33.01	15.68

Financial InsightsNGL Fine Chem

Income (P&L)
Cash Flow

- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 13.32% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
- Cash from Operations vs PAT
  Operating cash flow of Rs 20.47 cr is 0.5 times compared to the reported net profit of Rs 41.32 cr. (Source: Consolidated Financials)
- Decrease in Cash from Investing
  Company has used Rs 26.82 cr for investing activities which is an YoY decrease of 0.75%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

NGL Fine Chem Technicals

Buy / Sell Signals
Price Analysis
Pivot Levels & ATR
Chart

Stock doesn't have any Buy/Sell Signals.
Price Analysis Data details are not available.
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic - - - - - - -
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR - - -

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	-	-	-	-	-	-	-

	5 DAYS	14 DAYS	28 DAYS
ATR	-	-	-

NGL Fine Chem Peer Comparison

NGL Fine Chem Stock Performance
Ratio Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
NGL Fine Chem Stock Performance	5.00	18.45	26.30	30.38	-43.85	0.00	0.00
Syncom Form Stock Performance	8.24	15.15	7.80	11.55	39.19	0.00	0.00
Jagsonpal Pharm Stock Performance	-0.43	-4.40	-4.44	-0.88	46.97	79.52	2120.29
Bliss GVS Pharma Stock Performance	2.77	4.17	-0.92	-7.69	12.07	73.40	31.83
Lincoln Pharma Stock Performance	0.62	5.39	6.69	5.60	4.69	112.53	264.44
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
NGL Fine Chem	20.87	2.59	15.73	20.73	11.62	9.77	16.46	12.19	66.88	2.46	0.12	1.59
Syncom Form	39.62	5.37	8.78	12.89	6.25	3.17	14.59	9.61	0.34	2.58	0.25	-12.17
Jagsonpal Pharm	26.29	6.07	23.07	20.26	19.89	6.40	19.02	20.60	8.26	6.22	0.00	0.00
Bliss GVS Pharma	14.82	1.14	8.02	11.84	6.48	2.77	16.51	11.14	8.02	4.81	0.07	0.67
Lincoln Pharma	13.24	2.00	15.73	20.34	13.32	12.55	21.30	16.07	46.58	4.84	0.00	0.02
Add More

Annual Ratios (%)

Choose from Peers

Kopran Ltd
Wanbury Ltd
Anuh Pharma
Medicamen Bio
Nectar Lifesc

Choose from Stocks

See All Parameters

Peers InsightsNGL Fine Chem

Do you find these insights useful?

hate it
meh
love it

NGL Fine Chem Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing NGL Fine Chem Shareholding as on Mar 2025
Category Mar 2025 Dec 2024 Sep 2024 Jun 2024
Promoters 72.74 72.74 72.74 72.74
Pledge 0.00 0.00 0.00 0.00
FII 0.00 0.05 0.02 0.03
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 27.26 27.21 27.24 27.23
Showing Shareholding as on Mar 2025
Category No. of Shares Percentage % Change QoQ
Promoters 44,93,646 72.74 % 0.00
Pledge 0 0.00 % 0.00
FII 62 0.00 % -0.05
DII 62 0.00 % 0.00
MF 62 0.00 % 0.00
Others 16,84,254 27.26 % 0.04

Category	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Promoters	72.74	72.74	72.74	72.74
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.05	0.02	0.03
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	27.26	27.21	27.24	27.23

Category	No. of Shares	Percentage	% Change QoQ
Promoters	44,93,646	72.74 %	0.00
Pledge	0	0.00 %	0.00
FII	62	0.00 %	-0.05
DII	62	0.00 %	0.00
MF	62	0.00 %	0.00
Others	16,84,254	27.26 %	0.04

NGL Fine Chem MF Ownership

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.00
  Amount Invested (in Cr.)
- 0.01%
  % of AUM
- 0.00
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.00
  Amount Invested (in Cr.)
- 0.01%
  % of AUM
- 0.00
  % Change (MoM basis)

MF Ownership as on 30 April 2025

View all Mutual Fund Schemes

NGL Fine Chem Corporate Actions

NGL Fine Chem Board Meeting/AGM
NGL Fine Chem Dividends
Others

Meeting Date	Announced on	Purpose	Details
May 22, 2025	May 05, 2025	Board Meeting	Audited Results & Final Dividend
Feb 07, 2025	Jan 30, 2025	Board Meeting	Quarterly Results
Nov 08, 2024	Oct 28, 2024	Board Meeting	Quarterly Results
Aug 23, 2024	May 21, 2024	AGM	Book closure from Aug 17, 2024 to Aug 23, 2024
Aug 12, 2024	Aug 05, 2024	Board Meeting	Quarterly Results

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	35%	1.75	Aug 16, 2024	May 21, 2024
Final	35%	1.75	Aug 18, 2023	May 15, 2023
Final	35%	1.75	Jun 22, 2022	May 02, 2022
Final	35%	1.75	Aug 12, 2021	Jun 01, 2021
Final	35%	1.75	Aug 06, 2020	Jun 29, 2020

No other corporate actions details are available.

About NGL Fine Chem

NGL Fine - Chem Ltd., incorporated in the year 1981, is a Small Cap company (having a market cap of Rs 680.94 Crore) operating in Pharmaceuticals sector. NGL Fine - Chem Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Other Services for the year ending 31-Mar-2024. Show More

Executives
Auditors

DM
Dhananjay Mungale
Chairman & Ind.Director
RN
Rahul Nachane
Managing Director
RN
Rajesh Narayan Lawande
WholeTime Director & CFO
AR
Ajita R Nachane
Non Executive Woman Director
JS
Jayaram Sitaram
Independent Director
MV
Milind V Shinde
Independent Director
SM
Sarala Menon
Ind. Non-Executive Woman Director
PP
Pallavi Pednekar
Co. Secretary & Compl. Officer
Show More
Manek & Associates

Industry

Pharma - Indian

Key Indices Listed on

BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more

Address

301, E Square,Subhash Road,New Mumbai, Maharashtra - 400057

Contact

[email protected]

http://www.nglfinechem.com

More Details

FAQs about NGL Fine Chem share

1. What is NGL Fine Chem share price and what are the returns for NGL Fine Chem share?
NGL Fine Chem share price is Rs 1,313.60 as on 19 May, 2025, 03:41 PM IST. NGL Fine Chem share price is up by 5.00% based on previous share price of Rs 1,215.1. NGL Fine Chem share price trend:
- Last 1 Month: NGL Fine Chem share price moved up by 26.30%
- Last 12 Months: NGL Fine Chem share price moved down 43.85%
- Last 3 Years: NGL Fine Chem Share price moved remain unchanged by N.A.
2. What are the returns for NGL Fine Chem share?
Return Performance of NGL Fine Chem Shares:
- 1 Week: NGL Fine Chem share price moved up by 18.45%
- 1 Month: NGL Fine Chem share price moved up by 26.30%
3. Who owns NGL Fine Chem?
Following are the key changes to NGL Fine Chem shareholding:
- Promoter holding has not changed in last 9 months and holds 72.74 stake as on 31 Mar 2025
- Domestic Institutional Investors holding has not changed in last 9 months and holds 0.0 stake as on 31 Mar 2025
- Foreign Institutional Investors holding have gone down from 0.03 (30 Jun 2024) to 0.0 (31 Mar 2025)
- Other investor holding has gone up from 27.23 (30 Jun 2024) to 27.26 (31 Mar 2025)
4. What is the PE & PB ratio of NGL Fine Chem?
The PE ratio of NGL Fine Chem stands at 23.69, while the PB ratio is 2.94.
5. What is the CAGR of NGL Fine Chem?
The CAGR of NGL Fine Chem is 7.04.
6. What has been highest price of NGL Fine Chem share in last 52 weeks?
NGL Fine Chem share price saw a 52 week high of Rs 2,777.95 and 52 week low of Rs 957.00.
7. Is NGL Fine Chem giving dividend?
An equity Final dividend of Rs 1.75 per share was declared by NGL Fine - Chem Ltd. on 21 May 2024. So, company has declared a dividend of 35% on face value of Rs 5 per share. The ex dividend date was 16 Aug 2024.
8. How can I quickly analyze NGL Fine Chem stock?
NGL Fine Chem share can be quickly analyzed on following metrics:
- Stock's PE is 24.87
- Price to Book Ratio of 2.59
9. What's the market capitalization of NGL Fine Chem?
NGL Fine Chem share has a market capitalization of Rs 680.94 Cr. Within Pharmaceuticals sector, it's market cap rank is 82.
10. Who are the peers for NGL Fine Chem in Pharmaceuticals sector?
Top 10 Peers for NGL Fine Chem are Anuh Pharma Ltd., Lincoln Pharmaceuticals Ltd., Kopran Ltd., Bliss GVS Pharma Ltd., Nectar Lifesciences Ltd., Wanbury Ltd., Syncom Formulation (India) Ltd., Albert David Ltd., Jagsonpal Pharmaceuticals Ltd. and Medicamen Biotech Ltd.
11. What are the NGL Fine Chem quarterly results?
On Consoldiated basis, NGL Fine Chem reported a total income and loss of Rs 88.97 Cr and Rs 1.28 respectively for quarter ending 2024-12-31. Total Income and profit for the year ending 2024-03-31 was Rs 352.82 Cr and Rs 41.32 Cr.

Trending in Markets

Top Gainers As on 03:59 PM | 19 May 2025

Graphite India568.20

81.81 (16.82%)

Alembic Pharma1,028.65

115.71 (12.68%)

Delhivery351.25

30.40 (9.48%)

HEG528.70

38.11 (7.77%)

Caplin Point2,161.10

151.10 (7.52%)

Top Losers As on 03:59 PM | 19 May 2025

Vodafone Idea6.72

-0.66 (-8.82%)

CreditAccess Grameen1,120.50

-84.21 (-6.99%)

Apar Industries7,816.00

-412.00 (-5.01%)

GMR Infra87.43

-3.64 (-4.00%)

Godfrey Philips8,397.00

-321.50 (-3.69%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

ETPrime

NGL Fine Chem - NGL Fine - Chem Share Price

NGL Fine Chem share price insights

InsightsNGL Fine Chem

Key Metrics

Key Metrics

NGL Fine Chem Share Price Returns

ET Stock ScreenersTop Score Companies

NGL Fine Chem News & Analysis

NGL Fine Chem Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

NGL Fine Chem Share Recommendations

NGL Fine Chem Financials

Insights

Insights

Financial InsightsNGL Fine Chem

NGL Fine Chem Technicals

Pivot Levels

Average True Range

NGL Fine Chem Peer Comparison

Ratio Performance

Peers InsightsNGL Fine Chem

NGL Fine Chem Shareholding Pattern

NGL Fine Chem MF Ownership

Motilal Oswal BSE Healthcare ETF-G

Bandhan BSE Healthcare Index Direct-G

NGL Fine Chem Corporate Actions

About NGL Fine Chem

Executives

Auditors

More Details

FAQs about NGL Fine Chem share

Trending in Markets

Top Gainers As on 03:59 PM | 19 May 2025

Top Losers As on 03:59 PM | 19 May 2025

NGL Fine Chem Quick Links

Equity Quick Links

More from Markets

1 Day	4.99%
1 Week	17.77%
1 Month	23.91%
3 Months	30.2%
1 Year	-43.96%
3 Years	-33.0%
5 Years	300.89%